Hirsuteine

CAS No. 35467-43-7

Hirsuteine( —— )

Catalog No. M24309 CAS No. 35467-43-7

Hirsuteine is a natural product. It non-competitively antagonizes nicotine-mediated dopamine release by blocking ion permeation through nicotinic receptor channel complexes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 176 In Stock
10MG 266 In Stock
25MG 447 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Hirsuteine
  • Note
    Research use only, not for human use.
  • Brief Description
    Hirsuteine is a natural product. It non-competitively antagonizes nicotine-mediated dopamine release by blocking ion permeation through nicotinic receptor channel complexes.
  • Description
    Hirsuteine is a natural product. It non-competitively antagonizes nicotine-mediated dopamine release by blocking ion permeation through nicotinic receptor channel complexes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Dopamine
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    35467-43-7
  • Formula Weight
    366.45
  • Molecular Formula
    C22H26N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (272.89 mM)
  • SMILES
    O=C(OC)/C([C@H]([C@H](CN1CC2)C=C)C[C@]1([H])C3=C2C(C=CC=C4)=C4N3)=C/OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Non-competitive antagonism by hirsuteine of nicotinic receptor-mediated dopamine release from rat pheochromocytoma cells.Jpn J Pharmacol. 1993 Apr;61(4):351-6.
molnova catalog
related products
  • L-741626

    L-741626 is a selective antagonist of D2 dopamine receptor.

  • GR 103691

    GR 103691 is a potent, selective dopamine D3 receptor antagonist (Ki: 0.4 nM).?

  • BP-897

    BP-897 is the first, potent, selective partial dopamine D3 receptor agonist with Ki of 0.92 nM.